Accelerate the Translation of Modulator & Treg Cell Therapies to Redefine Immune Tolerance for Autoimmune, Inflammatory, & Neurodegenerative Diseases
With Nobel Prize recognition, clinical advances by Nektar Therapeutics and ORCA-T's potential as the first FDA-approved Treg cell therapy, Treg therapies are making waves.
At the 8th Treg-Directed Therapies Summit, Treg experts including Quell Therapeutics, Nektar Therapeutics, Sanofi, Yale and more, converge to overcome key challenges from cell targeting, Treg mechanisms of action and cytokine interactions, to indication selection, GMP and regulatory uncertainty, clinical trial design and established efficacy endpoints to push the boundaries of Treg application and clinical success.
Over three action-packed days, enjoy industry-tailored, data-packed presentations and interactive sessions led by pioneering companies unveiling their path to success to benchmark against the community.
Understanding and manipulating Tregs for the development of immunotherapy in autoimmune diseases, transplantation and cancer hold great promise for these patients. This summit is an ideal platform to learn and exchange the updated information and knowledge in the field.
Wanjun Chen, Senior Investigator, NIH
This meeting combined leading professionals in the Treg field and provided the opportunity to communicate on what is happening in the field and take key learnings back to the team.
Hong Jiang, Chief Scientific Officer, Avotres
I loved the content and particularly enjoyed that the presentations that covered Treg related therapies from early development to manufacturing and clinical development.
Zengli Guo, Associate Director, AstraZeneca
Explore the Full Event Guide
- A streamlined, single-track agenda so you can catch every insightful session without missing a moment
- A dedicated Treg Biology Focus Day to deepen mechanistic insights & accelerate translational impact
- 9 hours of dedicated networking, to be on a first-name basis with experts in the Treg community
- C-suite led panel discussions revealing real-world strategies and perspectives from the industry's top decision makers
- Exclusive new data presentations
- A 75% new speaker faculty bringing fresh observations to the stage
Official Partners
Attending Companies Include
Explore Related Events
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.